MedTrace Logo

Prognostic Value of Vitamin D Levels in Egyptian Females With Breast Cancer

NCT03594214 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 222

Last updated 2021-02-10

No results posted yet for this study

Summary

In our study; we aim to analyze the correlation between pre-treatment serum vitamin D (VD) levels and breast cancer prognostic features in newly diagnosed breast cancer patients presenting to our department.

Conditions

  • Vitamin D Deficiency

Interventions

DIAGNOSTIC_TEST

serum vitamin d level measured by ELISA kit

serum vitamin d level will be measured by a blood sample from newly diagnosed breast cancer patients just after diagnosis (either by surgery specimen or FNA or excisional biopsy specimen) and before receiving any type of treatment for breast cancer

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Dina B Saber, Ass.Lecturer · Assiut University

  • Samir Sh Eid, professor · Assiut University

  • Abeer F Amin, A.professor · Assiut University

  • Maha S El-Naggar, lecturer · Assiut University

  • Dalia T Kamal, lecturer · Assiut University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-08-31
Completion
2021-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03594214 on ClinicalTrials.gov